NIH-funded research R01 grant

Understanding how cell damage triggers immune responses in the lungs

Official title: Cell lysis-induced leukotriene synthesis activates type-2 immunity in the lung

Funded at University of Washington · NIH-11044420 · Data updated 2026-11-12

This study is looking at how certain immune cells in the lungs react to things like allergens and parasites, and it hopes to find new ways to help people with allergies and asthma by understanding how these immune responses work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startFebruary 1, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$880,735
NIH project number1R01HL172817-01A1
Project IDNIH-11044420 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from asthma or allergic diseases who may be affected by immune responses to allergens.

Less likely to help

Patients with non-allergic respiratory conditions or those not experiencing asthma or allergic reactions may not benefit from this research.

What this research studies

This research investigates how certain immune cells in the lungs respond to allergens and parasitic infections. It focuses on the role of specific signals released when cells are damaged, which activate a type of immune response known as type 2 immunity. By studying the production of leukotrienes and their impact on immune cell function, the research aims to uncover the mechanisms behind allergic reactions and asthma. Patients may benefit from insights that could lead to new treatments for these conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for asthma and allergic diseases by targeting the mechanisms that trigger these conditions.

How similar studies have gone: Previous research has shown promising results in understanding immune responses related to allergens, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Von Moltke, Jakob H. — University of Washington
  • Study coordinator: Von Moltke, Jakob H.

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.